MRK vs RVTY
By Alex · Tickerpine
Merck & Co., Inc. vs Revvity, Inc., side by side — the numbers that matter, in plain English. No “winner” hype; you decide.
| Metric | MRK | RVTY |
|---|---|---|
| Price | $128.66 | $113.02 |
| Market cap | $317.77B | $12.61B |
| P/E ratio | 36.2 | 54.3 |
| ROE | 18.94% | 3.23% |
| Profit margin | 13.59% | 8.26% |
| Revenue growth | 4.90% | 7.00% |
| Dividend yield | 2.64% | 0.25% |
| Beta | 0.22 | 1.11 |
Green = the more favorable figure for that metric (lower P/E, higher ROE, margin, growth and yield). Not a recommendation.
MRK vs RVTY in plain English
- MRK is the bigger company — about 25.2× the market cap of RVTY.
- MRK is cheaper on earnings (P/E 36.2 vs 54.3).
- MRK earns a higher return on equity (19% vs 3%).
- RVTY is growing revenue faster (7% vs 5%).
- MRK has the higher dividend yield (2.64% vs 0.25%).
How would $1,000 have done in each?
MRK return calculator
See what $1,000 in Merck & Co., Inc. would be worth today.
RVTY return calculator
See what $1,000 in Revvity, Inc. would be worth today.
Figures from public market data, may be delayed. Comparison is informational only — not investment advice.